Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03390712

Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection

Schizophrenia Spectrum and Other Psychotic Disorders Clinical Trial

Official title:
Mirror-image Study Exploring Relapse and Resource Utilization of Paliperidone Palmitate and Risperidone Long-acting Injection in Vitalité Health Network Patients

Clinical Trial Summary

The primary objective of this single-center multi-site retrospective chart review is to determine if paliperidone palmitate and/or risperidone long-acting injection can decrease the number of psychiatric relapses following their initiation in an inpatient acute psychiatric unit compared to oral antipsychotic therapy and determine if one treatment is superior to the other in this regard. This study will utilize a mirror-image design and incorporate up to a 3 years of follow-up following the index admission. Secondary objectives of this study will be to determine the change in hospital resource utilization for psychiatric reasons following treatment initiation, and to determine the difference in time to relapse.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03390712
Study type Observational
Source Réseau de Santé Vitalité Health Network
Contact
Status Enrolling by invitation
Phase N/A
Start date January 2, 2018
Completion date December 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Enrolling by invitation NCT03090490 - 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals N/A
Completed NCT03323437 - Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia Phase 4
Recruiting NCT06423651 - Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders N/A
Completed NCT06040944 - Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Recruiting NCT04452175 - Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia N/A
Completed NCT03501888 - Cognitive Behavior Therapy for Patients With Psychoses. N/A
Completed NCT05601063 - Ascertaining Diagnosis Classification With Elicited Speech
Recruiting NCT05877716 - EPI-MINN: Targeting Cognition and Motivation - National N/A
Completed NCT03955549 - Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial Phase 3
Completed NCT03235908 - Copeptin in Outcome Prediction of an Acute Psychotic Episode
Recruiting NCT05622201 - A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults Phase 2
Recruiting NCT05491486 - Mindfulness, Empathy and the Oxytocinergic System in Persons With Schizophrenia N/A
Completed NCT04916496 - Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical Activity N/A
Recruiting NCT04104347 - Metacognitive Training and Insight in Schizophrenia N/A
Recruiting NCT05664594 - State Representation in Early Psychosis - Project 4 N/A
Recruiting NCT05538832 - Remote State Representation in Early Psychosis Early Phase 1
Completed NCT02220504 - 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals N/A
Completed NCT04665401 - Personalizing Interventions Using Real-World Interactions N/A